NeuroScientific Biopharmaceuticals Limited (NSB.AX)

AUD 0.04

(5.71%)

Operating Expenses Summary of NeuroScientific Biopharmaceuticals Limited

  • NeuroScientific Biopharmaceuticals Limited's latest annual operating expenses in 2024 was 1.96 Million AUD , down -67.61% from previous year.
  • NeuroScientific Biopharmaceuticals Limited's latest quarterly operating expenses in 2024 FY was 1.96 Million AUD , down -67.61% from previous quarter.
  • NeuroScientific Biopharmaceuticals Limited reported a annual operating expenses of 6.06 Million AUD in annual operating expenses 2023, down -41.89% from previous year.
  • NeuroScientific Biopharmaceuticals Limited reported a annual operating expenses of 10.43 Million AUD in annual operating expenses 2022, up 150.8% from previous year.
  • NeuroScientific Biopharmaceuticals Limited reported a quarterly operating expenses of 696.24 Thousand AUD for 2024 Q4, down 0.0% from previous quarter.
  • NeuroScientific Biopharmaceuticals Limited reported a quarterly operating expenses of 1.96 Million AUD for 2024 FY, down -67.61% from previous quarter.

Annual Operating Expenses Chart of NeuroScientific Biopharmaceuticals Limited (2024 - 2016)

Historical Annual Operating Expenses of NeuroScientific Biopharmaceuticals Limited (2024 - 2016)

Year Operating Expenses Operating Expenses Growth
2024 1.96 Million AUD -67.61%
2023 6.06 Million AUD -41.89%
2022 10.43 Million AUD 150.8%
2021 4.16 Million AUD 44.29%
2020 2.88 Million AUD 80.71%
2019 1.59 Million AUD 73.94%
2018 917.73 Thousand AUD 217.74%
2017 288.83 Thousand AUD 31.85%
2016 219.06 Thousand AUD 0.0%

Peer Operating Expenses Comparison of NeuroScientific Biopharmaceuticals Limited

Name Operating Expenses Operating Expenses Difference
EZZ Life Science Holdings Limited 39.57 Million AUD 95.034%
Anatara Lifesciences Ltd 710.21 Thousand AUD -176.707%
Zelira Therapeutics Limited 5.94 Million AUD 66.963%
Biome Australia Limited 7.91 Million AUD 75.159%
Patrys Limited 4.93 Million AUD 60.164%
Orthocell Limited 15.36 Million AUD 87.214%
Imugene Limited 135.09 Million AUD 98.545%
Noxopharm Limited 7 Million AUD 71.926%
PYC Therapeutics Limited 60.91 Million AUD 96.774%
Chimeric Therapeutics Limited 19.76 Million AUD 90.058%
Prescient Therapeutics Limited 10.89 Million AUD 81.968%
Proteomics International Laboratories Limited 892.14 Thousand AUD -120.281%
Cynata Therapeutics Limited 11.12 Million AUD 82.333%
CSL Limited 7.56 Billion AUD 99.974%
Arovella Therapeutics Limited 10.78 Million AUD 81.779%
Bio-Gene Technology Limited 2.76 Million AUD 28.822%
Clinuvel Pharmaceuticals Limited 31.29 Million AUD 93.721%
Starpharma Holdings Limited 22.81 Million AUD 91.387%
Nanollose Limited 12.5 Thousand AUD -15620.51%
Memphasys Limited 3.67 Million AUD 46.574%
Invex Therapeutics Ltd 3.34 Million AUD 41.265%
Amplia Therapeutics Limited 8.43 Million AUD 76.704%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD -226.546%
Island Pharmaceuticals Limited 4.12 Million AUD 52.362%
Race Oncology Limited 14.77 Million AUD 86.695%
Nyrada Inc. 4.55 Million AUD 56.857%
Telix Pharmaceuticals Limited 269.26 Million AUD 99.27%
Dimerix Limited 25.64 Million AUD 92.336%
PharmAust Limited 6.65 Million AUD 70.479%
Immutep Limited 42.87 Million AUD 95.416%
Clarity Pharmaceuticals Ltd 56.3 Million AUD 96.51%
Alterity Therapeutics Limited 23.4 Million AUD 91.604%
BTC Health Limited -1.03 Million AUD 289.159%
Acrux Limited 8.55 Million AUD 77.015%
Neuren Pharmaceuticals Limited 32.69 Million AUD 93.99%
Biotron Limited 5.11 Million AUD 61.547%
Tissue Repair Ltd 6.66 Million AUD 70.522%
AdAlta Limited 6.76 Million AUD 70.97%
Radiopharm Theranostics Limited 299.22 Thousand AUD -556.764%
Hexima Limited 1 Million AUD -94.817%
AnteoTech Limited 12.18 Million AUD 83.874%
Paradigm Biopharmaceuticals Limited 65.1 Million AUD 96.981%
Recce Pharmaceuticals Ltd 21.68 Million AUD 90.937%
Avecho Biotechnology Limited 4.54 Million AUD 56.765%
Actinogen Medical Limited 22.77 Million AUD 91.369%
Immuron Limited 9.13 Million AUD 78.494%
Argenica Therapeutics Limited 8.26 Million AUD 76.234%